My research background is in immunology, with work spanning immune checkpoints, mucosal immunity, inflammation, and tumor signaling. These are selected peer-reviewed publications and conference abstracts I co-authored.

Research articles

• Lin, W. W., Huang, S., Balmert, O., Bjordahl, R., Ware, B. C., Moshayedi, A., Nguyen, J., Ware, C. F., & Sedy, J. R. (2026). Mutant HVEM in lymphoma disrupts BTLA and CD160 regulation of anti-tumor signaling. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1914960

• Stienne, C., Virgen-Slane, R., Elmen, L., Veny, M., Huang, S., Nguyen, J., Chappell, E., Balmert, M. O., Shui, J. W., Hurchla, M. A., Kronenberg, M., Peterson, S. N., Murphy, K. M., Ware, C. F., & Sedy, J. R. (2022). BTLA signaling in conventional and regulatory lymphocytes coordinately tempers humoral immunity in the intestinal mucosa. Cell Reports, 38(12), 110553. https://doi.org/10.1016/j.celrep.2022.110553

• Veny, M., Grases, D., Kucharova, K., Lin, W. W., Nguyen, J., Huang, S., Ware, C. F., Ranscht, B., & Sedy, J. R. (2020). Contactin-1 is required for peripheral innervation and immune homeostasis within the intestinal mucosa. Frontiers in Immunology, 11, 1268. https://doi.org/10.3389/fimmu.2020.01268

Conference abstracts

• Sedy, J. R., Balmert, M. O., Nguyen, J., Ware, B. C., Bjordahl, R., Norris, P. S., Miller, B. R., Aivazian, D., & Ware, C. F. (2017). Cancer mutations targeting TNFRSF14 alter microenvironment checkpoint interactions to limit tumor clearance by cytotoxic cells. The Journal of Immunology, 198(Supplement 1), 141.10. https://doi.org/10.4049/jimmunol.198.Supp.141.10

• Sedy, J. R., Veny, M., Nguyen, J., Balmert, M. O., Niemela, N., Norris, P. S., & Ware, C. F. (2016). Targeting the HVEM-BTLA-CD160-LIGHT network in psoriasis. The Journal of Immunology, 196(1 Supplement), 124.42. https://doi.org/10.4049/jimmunol.196.Supp.124.42

Publication details and links were checked against the publishers' records on September 14, 2026.